Download PDF
kleintier konkret 2018; 21(01): 41-45
DOI: 10.1055/s-0044-100428
Labor
Endokrinologie
Georg Thieme Verlag KG Stuttgart · New York

Cushing beim Hund, ja oder nein? – Erweiterung in der Diagnostik und Neues zur Therapiekontrolle

Ruth Klein
Further Information

Publication History

Publication Date:
14 March 2018 (online)

Also available at
    Permissions and Reprints All articles of this category

Cushing war und ist ein immer aktuelles Thema beim Hund, zu dem regelmäßig neue Erkenntnisse gewonnen werden. Dieser Beitrag informiert über die erweiterte Diagnostik und Neuigkeiten in der Therapiekontrolle.
 

  • Literatur

  • 1 Verstraete A, Thoonen J. Twee nieuwe gevallen van hypophysaire stoornissen biji de hond. Vlaams diergeneesk. Tijdschr 1939; 8: 304
    Search in Google Scholar
  • 2 Coffin DL, Munson TO. Endocrine diseases of the dog associated with hair loss: Sertoli cell tumor of testis, hypothyroidism, canine Cushingʼs syndrome. J Am Vet Med Assoc 1953; 123 (920) 402-408
    PubMedSearch in Google Scholar
  • 3 Gallo-Payet N. 60 Years of POMC: Adrenal and extra-adrenal functions of ACTH. J Mol Endocrinol 2016; 56 (04) 135-156
    CrossrefPubMedSearch in Google Scholar
  • 4 Wierzbicka JM, Zmijewski MA, Piotrowska A. et al. Bioactive forms of vitamin D selectively stimulate the skin analog of the hypothalamus-pituitary-adrenal axis in human epidermal keratinocytes. Mol Cell Endocrinol 2016; 437: 312-322
    CrossrefPubMedSearch in Google Scholar
  • 5 Behrend EN, Kooistra HS, Nelson R. et al. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med 2013; 27: 1292-1304
    CrossrefPubMedSearch in Google Scholar
  • 6 Mealey KL, Gay JM, Martin LG. et al. Comparison of the hypothalamic-pituitary – adrenal axis in MDR1-1δ and MDR1 wildtype dogs. J Vet Emerg Crit Care 2007; 17 (01) 61-66
    CrossrefSearch in Google Scholar
  • 7 Bryan HM, Adams AG, Invik RM. et al. Hair as a meaningful measure of baseline cortisol levels over time in dogs. J Am Assoc Lab Anim Sci 2013; 52 (02) 189-196
    PubMedSearch in Google Scholar
  • 8 Ouschan C, Kuchar A, Möstl E. Measurement of cortisol in dog hair: a noninvasive tool for the diagnosis of hypercortisolism. Vet Dermatol 2013; 24 (04) 428-431
    CrossrefPubMedSearch in Google Scholar
  • 9 Monroe WE, Panciera DL, Zimmerman KL. Concentrations of noncortisol adrenal steroids in response to ACTH in dogs with adrenal-dependent hyperadrenocorticism, pituitary-dependent hyperadrenocorticism, and nonadrenal illness. J Vet Intern Med 2012; 26: 945-952
    CrossrefPubMedSearch in Google Scholar
  • 10 Frank LA, Henry GA, Whittemore JC. et al. Serum cortisol concentrations in dogs with pituitary-dependent hyperadrenocorticism and atypical hyperadrenocorticism. J Vet Intern Med 2015; 29: 193-199
    CrossrefPubMedSearch in Google Scholar
  • 11 Hoffrogge S, Fels L, Schmicke M. et al. Atypisches Cushing-Syndrom bei einem Hund. Ein Fallbericht. Tieraerztl Prax 2017; 45 (K): 186-192
    Search in Google Scholar
  • 12 Ristic JM, Ramsey IK, Heath EM. et al. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. J Vet Intern Med 2002; 16: 433-439
    CrossrefPubMedSearch in Google Scholar
  • 13 Grams N. Gesundheit! Ein Buch nicht ohne Nebenwirkungen. Heidelberg: Springer; 2018
    Search in Google Scholar
  • 14 Sieber-Ruckstuhl NS, Boretti FS, Wenger M. et al. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Vet Rec 2008; 163: 477-481
    CrossrefPubMedSearch in Google Scholar
  • 15 Kinga KB, Morton JM. Incidence and risk factors for hypoadrenocorticism in dogs treated with trilostane. Vet J 2017; 230: 24-29
    CrossrefPubMedSearch in Google Scholar
  • 16 Macfarlane L, Parkin T, Ramsey I. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs. Vet Rec 2016; 179 (23) 597
    CrossrefPubMedSearch in Google Scholar
  • 17 Boretti FS, Holzthüm J, Reusch CE. et al. Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment. Schweiz Arch Tierheilkd 2016; 158 (09) 631-638
    CrossrefPubMedSearch in Google Scholar